DuPont De Nemours (DD) Expands Bioprocessing Tools, Is The Stock Still Cheap?

DuPont de Nemours (DD) just expanded its bioprocessing toolkit with AmberChrom SIL silica gel, a reverse phase media tailored for peptide therapeutics like GLP-1 receptor agonists. This development is putting fresh attention on how its healthcare solutions support complex drug manufacturing. Recent trading has leaned positive for DuPont de Nemours, with the share price at US$136.55 after a 1-day share price return of 1.07% and a 7-day share price return of 4.68%. A fresh product launch and an...